Advertisement

Topics

"Safety and Efficacy Study of EGT0001442 in Subjects With Type 2 Diabetes Mellitus" Drugs and Medication Database

19:03 EST 16th February 2019 | BioPortfolio

Here are the most relevant "Safety and Efficacy Study of EGT0001442 in Subjects With Type 2 Diabetes Mellitus" Drugs and Medications that we have found in our database.

More Information about "Safety and Efficacy Study of EGT0001442 in Subjects With Type 2 Diabetes Mellitus" on BioPortfolio

We have published hundreds of Safety and Efficacy Study of EGT0001442 in Subjects With Type 2 Diabetes Mellitus news stories on BioPortfolio along with dozens of Safety and Efficacy Study of EGT0001442 in Subjects With Type 2 Diabetes Mellitus Clinical Trials and PubMed Articles about Safety and Efficacy Study of EGT0001442 in Subjects With Type 2 Diabetes Mellitus for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Safety and Efficacy Study of EGT0001442 in Subjects With Type 2 Diabetes Mellitus Companies in our database. You can also find out about relevant Safety and Efficacy Study of EGT0001442 in Subjects With Type 2 Diabetes Mellitus Drugs and Medications on this site too.

Showing "Safety Efficacy Study EGT0001442 Subjects With Type Diabetes" Drugs and Medications, all 3

Possibly Relevant

Nesina [takeda pharmaceuticals america, inc.]

These highlights do not include all the information needed to use NESINA safely and effectively. See full prescribing information for NESINA. NESINA (alogliptin) tablets, for oral use Initial U.S. Approval: 2013

Alogliptin [perrigo new york inc]

These highlights do not include all the information needed to use ALOGLIPTIN TABLETS safely and effectively. See full prescribing information for ALOGLIPTIN TABLETS. Alogliptin Tablets, for oral use Initial U.S. Approval: 2013

Metformin hydrochloride [blenheim pharmacal, inc.]

METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, USP



Advertisement
Quick Search
Advertisement
Advertisement